Entrepreneur Dilemmas - Should You Provide a Place for People to Vape Outside Your Workplace? Should you allow your staff to vape or use e-cigs at work? This is just as big of a question as whether or not to allow people to smoke outside of the office building today. Unfortunately, this is all a bit of a hazy issue for most employers and employees today. Those who don't want to allow smoking outside of their business aren't sure about whether to allow employees to turn on their battery-powered … [Read more...]
DES Tragedy ** Mothers, Daughters, Sons, 3rd Generation and Beyond, Transgender
Many women across the world have been involved in keeping the message of the DES Tragedy alive. We provide education to the DES Exposed, provide resources for patients to bring to their doctors and continue to push for research. We welcome everyone from the DES community -- Mothers, Daughters, Sons, 3rd Generation and Beyond, Transgender, and family and friends of DES-exposed -- as well as those interested in learning more. Description The DES tragedy of in-utero exposure and … [Read more...]
The OraQuick In-Home HIV Test now FDA Approved
FDA approves 'The OraQuick In-Home HIV Test' The U.S. Food and Drug Administration today approved the OraQuick In-Home HIV Test, the first over-the-counter home-use rapid HIV test kit to detect the presence of antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2). HIV is the virus that causes acquired immune deficiency syndrome (AIDS). The OraQuick In-Home HIV Test is designed to allow individuals to collect an oral fluid sample by swabbing the upper and lower … [Read more...]
NORD: 1st Annual U.S. Conference On Rare Diseases & Orphan Products
Stellar Lineup of Speakers Announced for U.S. Conference On Rare Diseases And Orphan Products Join all stakeholders – patient advocates, researchers, government, industry, investors – in this 1st Annual Summit featuring thought leaders and focusing on collaboration! You are invited to the 1st Annual U.S. Conference on Rare Diseases and Orphan Products to be hosted by the National Organization for Rare Disorders (NORD) and the Drug Information Association (DIA). Additional support … [Read more...]
NORD e-News: July 2011 Edition
NORD e-News: July 2011 Edition Send a Message to Congress on NORD Website Federal budget cuts have been proposed to Medicare reimbursement for drugs and biologics as part of a compromise to raise the debt ceiling. One proposal under consideration is to move orphan products from Medicare Part B coverage to Part D. This could greatly increase the cost for some patients and families dependent on lifesaving orphan drugs and biologics. You can quickly and easily submit a message to President … [Read more...]